Baillie Gifford & Co. cut its stake in Fabrinet (NYSE:FN – Free Report) by 16.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 464,564 shares of the technology company’s stock after selling 88,594 shares during the period. Baillie Gifford & Co. owned about 1.30% of Fabrinet worth $211,507,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in FN. Westend Capital Management LLC purchased a new stake in shares of Fabrinet during the fourth quarter valued at approximately $29,000. Root Financial Partners LLC purchased a new stake in shares of Fabrinet during the third quarter valued at approximately $34,000. USA Financial Formulas purchased a new stake in shares of Fabrinet during the fourth quarter valued at approximately $49,000. CI Investments Inc. boosted its stake in shares of Fabrinet by 40.6% during the third quarter. CI Investments Inc. now owns 149 shares of the technology company’s stock valued at $54,000 after purchasing an additional 43 shares during the period. Finally, Larson Financial Group LLC boosted its stake in shares of Fabrinet by 25.8% during the third quarter. Larson Financial Group LLC now owns 161 shares of the technology company’s stock valued at $59,000 after purchasing an additional 33 shares during the period. 97.38% of the stock is currently owned by hedge funds and other institutional investors.
Fabrinet Stock Up 0.2%
NYSE FN opened at $663.49 on Monday. Fabrinet has a 52 week low of $167.33 and a 52 week high of $679.57. The firm has a market capitalization of $23.77 billion, a P/E ratio of 63.55 and a beta of 1.04. The company has a 50-day moving average price of $531.84 and a 200-day moving average price of $474.10.
Analysts Set New Price Targets
FN has been the subject of a number of research analyst reports. B. Riley Financial raised their price target on Fabrinet from $366.00 to $452.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 3rd. Susquehanna raised their price target on Fabrinet from $550.00 to $570.00 and gave the stock a “positive” rating in a research note on Thursday, January 22nd. Needham & Company LLC reaffirmed a “buy” rating and issued a $540.00 price target on shares of Fabrinet in a research note on Tuesday, February 3rd. Northland Securities set a $600.00 price objective on shares of Fabrinet in a report on Monday, December 22nd. Finally, Wolfe Research upgraded shares of Fabrinet from a “peer perform” rating to an “outperform” rating and set a $540.00 price objective for the company in a report on Wednesday, February 4th. Six investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $541.25.
View Our Latest Research Report on FN
Fabrinet Profile
Fabrinet is a global provider of advanced optical packaging and precision optical, electro‐mechanical and electronic manufacturing services (CEM). The company specializes in complex manufacturing processes for original equipment manufacturers (OEMs) in communications, data center, industrial, instrumentation and medical markets. Key capabilities include high‐precision fiber alignment, micro‐assembly, testing and diagnostics, and integration of electro‐optic subassemblies.
Incorporated in 2000, Fabrinet operates under a corporate structure headquartered in Singapore with additional regional offices and design centers in the Americas, Europe and Asia.
Featured Stories
Want to see what other hedge funds are holding FN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fabrinet (NYSE:FN – Free Report).
Receive News & Ratings for Fabrinet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fabrinet and related companies with MarketBeat.com's FREE daily email newsletter.
